Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
2001 1
2005 1
2006 1
2008 1
2009 9
2010 10
2011 4
2012 4
2013 5
2014 6
2015 14
2016 10
2017 21
2018 19
2019 30
2020 31
2021 36
2022 22
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30353269

187 results

Results by year

Filters applied: . Clear all
Page 1
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
Hernandez MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, Manero J, Campos-Fernandez C, Martin-Domenech R, Del Pino-Montes J, Manrique S, Castro-Villegas MC, Ruiz-Montesinos D, Sanchez-Alonso F, Diaz-Gonzalez F, Cea-Calvo L, Gómez-Reino JJ; BIOBADASER Study Group. Hernandez MV, et al. Rheumatol Int. 2019 Mar;39(3):509-515. doi: 10.1007/s00296-018-4177-z. Epub 2018 Oct 24. Rheumatol Int. 2019. PMID: 30353269 Free article.
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
Pombo-Suarez M, Sanchez-Piedra C, Garcia-Magallón B, Pérez-Gómez A, Manrique-Arija S, Martín-Doménech R, Colazo M, Campos C, Campos J, Del Pino-Montes J, Arteaga MJ, Cea-Calvo L, Díaz-González F, Gómez-Reino JJ. Pombo-Suarez M, et al. Clin Rheumatol. 2021 Oct;40(10):3979-3988. doi: 10.1007/s10067-021-05742-3. Epub 2021 Apr 27. Clin Rheumatol. 2021. PMID: 33907904
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis.
Pombo-Suárez M, Seoane-Mato D, Díaz-González F, Cea-Calvo L, Sánchez-Alonso F, Sánchez-Jareño M, Jovani V, García-Magallón B, Martínez-González O, Campos-Fernández C, Manero J, Díaz-Torne C, Bohórquez C, Ros-Vilamajó I, Pérez-Vera Y, Castrejón I. Pombo-Suárez M, et al. Musculoskeletal Care. 2023 Mar;21(1):189-197. doi: 10.1002/msc.1684. Epub 2022 Aug 22. Musculoskeletal Care. 2023. PMID: 35996810
The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs-BioRx.si.
Rotar Ž, Tomšič M, Praprotnik S; Slovenian Rheumatologists. Rotar Ž, et al. Clin Rheumatol. 2019 Feb;38(2):297-305. doi: 10.1007/s10067-018-4324-7. Epub 2018 Oct 15. Clin Rheumatol. 2019. PMID: 30324406
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Iannone F, Santo L, Anelli MG, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Carlino G, Casilli O, Cacciapaglia F, Zuccaro C, Falappone PC, Cantatore FP, Muratore M, Lapadula G. Iannone F, et al. Semin Arthritis Rheum. 2017 Aug;47(1):108-114. doi: 10.1016/j.semarthrit.2017.01.008. Epub 2017 Jan 18. Semin Arthritis Rheum. 2017. PMID: 28216195
Long-Term Retention Rate of Golimumab in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting.
Serrano-Benavente B, Valor L, Del Río Blasco T, Janta I, González Benítez R, Nieto-González JC, Martínez-Barrio J, Ovalles Bonilla JG, Ariza A, López-Longo FJ, Álvaro-Gracia JM, Monteagudo I, González-Fernández CM. Serrano-Benavente B, et al. J Clin Rheumatol. 2022 Jan 1;28(1):e150-e155. doi: 10.1097/RHU.0000000000001695. J Clin Rheumatol. 2022. PMID: 33492028
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
Favalli EG, Becciolini A, Carletto A, Conti F, Amato G, Fusaro E, Quartuccio L, Egan CG, Lo Monaco A, Benucci M, Salaffi F, Semeraro A, Parisi S, Ceccarelli F, Piazza I, Foti R. Favalli EG, et al. Rheumatol Int. 2020 Feb;40(2):263-272. doi: 10.1007/s00296-019-04416-3. Epub 2019 Aug 21. Rheumatol Int. 2020. PMID: 31435754
187 results